Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
9077 | 1190 | 34.7 | 71% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
332 | 3 | ERYTHROPOIETIN//ANEMIA//FERRITIN | 37752 |
388 | 2 | ERYTHROPOIETIN//ANEMIA//IRON DEFICIENCY | 16969 |
9077 | 1 | INTRAVENOUS IRON//IRON SUCROSE//IRON DEXTRAN | 1190 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | INTRAVENOUS IRON | authKW | 1958324 | 11% | 61% | 126 |
2 | IRON SUCROSE | authKW | 1713475 | 8% | 73% | 91 |
3 | IRON DEXTRAN | authKW | 833591 | 5% | 57% | 57 |
4 | FERRIC GLUCONATE | authKW | 463131 | 2% | 95% | 19 |
5 | FERRIC CARBOXYMALTOSE | authKW | 427613 | 3% | 56% | 30 |
6 | IRON GLUCONATE | authKW | 295821 | 1% | 82% | 14 |
7 | SODIUM FERRIC GLUCONATE | authKW | 284214 | 1% | 92% | 12 |
8 | IRON DEFICIENCY | authKW | 267772 | 14% | 6% | 161 |
9 | TRANSFERRIN SATURATION | authKW | 267757 | 4% | 23% | 45 |
10 | INTRAVENOUS IRON THERAPY | authKW | 255068 | 1% | 76% | 13 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Urology & Nephrology | 32323 | 48% | 0% | 570 |
2 | Transplantation | 2587 | 10% | 0% | 119 |
3 | Gastroenterology & Hepatology | 1516 | 11% | 0% | 136 |
4 | Hematology | 612 | 8% | 0% | 91 |
5 | Medicine, General & Internal | 376 | 10% | 0% | 116 |
6 | Pharmacology & Pharmacy | 176 | 10% | 0% | 115 |
7 | Engineering, Biomedical | 99 | 3% | 0% | 34 |
8 | Nutrition & Dietetics | 78 | 3% | 0% | 33 |
9 | Pediatrics | 53 | 3% | 0% | 40 |
10 | Medicine, Research & Experimental | 52 | 4% | 0% | 44 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | HOP PRIVE CLAUDE GALIEN | 76975 | 0% | 100% | 3 |
2 | CHEM PRECLIN DEV | 57730 | 0% | 75% | 3 |
3 | HOSP ALEMAN | 57139 | 1% | 32% | 7 |
4 | COMPTABILITAT ANALIT | 51317 | 0% | 100% | 2 |
5 | SERV NEPHROL DIALYSE ADULTES | 51317 | 0% | 100% | 2 |
6 | UNIV HOSP SKANE | 38485 | 0% | 50% | 3 |
7 | EURODIAL | 34210 | 0% | 67% | 2 |
8 | BIOCHEM MOLBIOL MOL ZELLBIOL 2 | 25658 | 0% | 100% | 1 |
9 | BIOMARKER SOC | 25658 | 0% | 100% | 1 |
10 | BIOMETRY EPIDEMIOL IBE | 25658 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | AMERICAN JOURNAL OF KIDNEY DISEASES | 16108 | 6% | 1% | 73 |
2 | NEPHROLOGY DIALYSIS TRANSPLANTATION | 16021 | 7% | 1% | 88 |
3 | SEMINARS IN DIALYSIS | 8078 | 2% | 1% | 24 |
4 | CLINICAL NEPHROLOGY | 7466 | 3% | 1% | 38 |
5 | KIDNEY INTERNATIONAL | 6096 | 5% | 0% | 59 |
6 | CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 5284 | 2% | 1% | 24 |
7 | DIALYSIS & TRANSPLANTATION | 4502 | 1% | 1% | 15 |
8 | JOURNAL OF CROHNS & COLITIS | 4293 | 1% | 1% | 13 |
9 | AMERICAN JOURNAL OF NEPHROLOGY | 4163 | 2% | 1% | 23 |
10 | JOURNAL OF NEPHROLOGY | 3897 | 2% | 1% | 19 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | INTRAVENOUS IRON | 1958324 | 11% | 61% | 126 | Search INTRAVENOUS+IRON | Search INTRAVENOUS+IRON |
2 | IRON SUCROSE | 1713475 | 8% | 73% | 91 | Search IRON+SUCROSE | Search IRON+SUCROSE |
3 | IRON DEXTRAN | 833591 | 5% | 57% | 57 | Search IRON+DEXTRAN | Search IRON+DEXTRAN |
4 | FERRIC GLUCONATE | 463131 | 2% | 95% | 19 | Search FERRIC+GLUCONATE | Search FERRIC+GLUCONATE |
5 | FERRIC CARBOXYMALTOSE | 427613 | 3% | 56% | 30 | Search FERRIC+CARBOXYMALTOSE | Search FERRIC+CARBOXYMALTOSE |
6 | IRON GLUCONATE | 295821 | 1% | 82% | 14 | Search IRON+GLUCONATE | Search IRON+GLUCONATE |
7 | SODIUM FERRIC GLUCONATE | 284214 | 1% | 92% | 12 | Search SODIUM+FERRIC+GLUCONATE | Search SODIUM+FERRIC+GLUCONATE |
8 | IRON DEFICIENCY | 267772 | 14% | 6% | 161 | Search IRON+DEFICIENCY | Search IRON+DEFICIENCY |
9 | TRANSFERRIN SATURATION | 267757 | 4% | 23% | 45 | Search TRANSFERRIN+SATURATION | Search TRANSFERRIN+SATURATION |
10 | INTRAVENOUS IRON THERAPY | 255068 | 1% | 76% | 13 | Search INTRAVENOUS+IRON+THERAPY | Search INTRAVENOUS+IRON+THERAPY |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MACDOUGALL, IC , BIRCHER, AJ , ECKARDT, KU , OBRADOR, GT , POLLOCK, CA , STENVINKEL, P , SWINKELS, DW , WANNER, C , WEISS, G , CHERTOW, GM , (2016) IRON MANAGEMENT IN CHRONIC KIDNEY DISEASE: CONCLUSIONS FROM A "KIDNEY DISEASE: IMPROVING GLOBAL OUTCOMES" (KDIGO) CONTROVERSIES CONFERENCE.KIDNEY INTERNATIONAL. VOL. 89. ISSUE 1. P. 28 -39 | 60 | 54% | 16 |
2 | HORL, WH , (2007) CLINICAL ASPECTS OF IRON USE IN THE ANEMIA OF KIDNEY DISEASE.JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. VOL. 18. ISSUE 2. P. 382 -393 | 95 | 74% | 46 |
3 | VAZIRI, ND , KALANTAR-ZADEH, K , WISH, JB , (2016) NEW OPTIONS FOR IRON SUPPLEMENTATION IN MAINTENANCE HEMODIALYSIS PATIENTS.AMERICAN JOURNAL OF KIDNEY DISEASES. VOL. 67. ISSUE 3. P. 367 -375 | 51 | 89% | 1 |
4 | ROSTOKER, G , VAZIRI, ND , FISHBANE, S , (2016) IATROGENIC IRON OVERLOAD IN DIALYSIS PATIENTS AT THE BEGINNING OF THE 21ST CENTURY.DRUGS. VOL. 76. ISSUE 7. P. 741 -757 | 51 | 62% | 2 |
5 | PANDEY, R , DALOUL, R , COYNE, DW , (2016) IRON TREATMENT STRATEGIES IN DIALYSIS-DEPENDENT CKD.SEMINARS IN NEPHROLOGY. VOL. 36. ISSUE 2. P. 105 -111 | 40 | 91% | 0 |
6 | MANTADAKIS, E , (2016) ADVANCES IN PEDIATRIC INTRAVENOUS IRON THERAPY.PEDIATRIC BLOOD & CANCER. VOL. 63. ISSUE 1. P. 11 -16 | 43 | 73% | 2 |
7 | AUERBACH, M , BALLARD, H , (2010) CLINICAL USE OF INTRAVENOUS IRON: ADMINISTRATION, EFFICACY, AND SAFETY.HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM. VOL. . ISSUE . P. 338-347 | 41 | 85% | 62 |
8 | DIGNASS, AU , GASCHE, C , BETTENWORTH, D , BIRGEGARD, G , DANESE, S , GISBERT, JP , GOMOLLON, F , IQBAL, T , KATSANOS, K , KOUTROUBAKIS, I , ET AL (2015) EUROPEAN CONSENSUS ON THE DIAGNOSIS AND MANAGEMENT OF IRON DEFICIENCY AND ANAEMIA IN INFLAMMATORY BOWEL DISEASES.JOURNAL OF CROHNS & COLITIS. VOL. 9. ISSUE 3. P. 211 -222 | 50 | 50% | 30 |
9 | CHARYTAN, DM , PAI, AB , CHAN, CT , COYNE, DW , HUNG, AM , KOVESDY, CP , FISHBANE, S , (2015) CONSIDERATIONS AND CHALLENGES IN DEFINING OPTIMAL IRON UTILIZATION IN HEMODIALYSIS.JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. VOL. 26. ISSUE 6. P. 1238 -1247 | 46 | 64% | 13 |
10 | GOMOLLON, F , GISBERT, JP , (2013) CURRENT MANAGEMENT OF IRON DEFICIENCY ANEMIA IN INFLAMMATORY BOWEL DISEASES: A PRACTICAL GUIDE.DRUGS. VOL. 73. ISSUE 16. P. 1761-1770 | 54 | 63% | 11 |
Classes with closest relation at Level 1 |